Terraform Labs co-founder Do Kwon could face a separate criminal trial in South Korea despite receiving a 15-year prison sentence in the United States.
South Korea prosecutors said a domestic conviction could add decades to Kwon’s prison time under local financial laws.
Kwon was sentenced last week in the US for his role in the 2022 collapse of the Terra ecosystem, which wiped out roughly $40 billion in value.
Merriam-Webster has declared “slop” its 2025 Word of the Year, highlighting growing concern over the spread of low-quality, AI-generated content across the internet.
The dictionary publisher said the term reflects rising unease with digital writing that appears polished and fluent but lacks depth, originality or clear human voice.
Argenx (ARGX) announced the discontinuation of its Phase 3 UplighTED studies for efgartigimod SC in Thyroid Eye Disease (TED) after an interim analysis by an Independent Data Monitoring Committee (IDMC) indicated futility.
United States crypto regulation is entering a new phase after the Commodity Futures Trading Commission announced it would withdraw legacy digital asset guidance seen as misaligned with today’s market realities.
The decision, confirmed on 11 December, signals a regulatory pivot that could reduce compliance burdens and widen institutional access to crypto markets across the country.
Standard Chartered and Coinbase have expanded their strategic partnership to build trading, custody and financing infrastructure for institutional cryptocurrency clients.
The British multinational bank said the collaboration will focus on developing secure and compliant digital asset services tailored to large financial institutions.
Natera (NASDAQ:NTRA), a global leader in cell-free DNA and precision medicine, and MEDSIR (Medica Scientia Innovation Research), a global leader in oncology research, today announced their collaboration on the MiRaDoR (NCT05708235) study.
Acadia Pharmaceuticals (NASDAQ:ACAD) announced today that the U.S. Food and Drug Administration (FDA) has approved DAYBUE® STIX (trofinetide) for oral solution, a new dye- and preservative-free powder formulation of trofinetide for the treatment of Rett syndrome in both adult and pediatric patients aged two years and older.
Relay Therapeutics (NASDAQ:RLAY) presented promising subset efficacy data from its ReDiscover program at the 2025 San Antonio Breast Cancer Symposium (SABCS), showcasing the combination of zovegalisib (RLY-2608) and fulvestrant in a cohort of 52 patients with estrogen receptor-positive breast cancer.
The United States has taken a landmark step in financial regulation after the Office of the Comptroller of the Currency granted conditional approval for five leading crypto companies to operate as national trust banks.
Ripple, Circle, Paxos, BitGo and Fidelity Digital Assets are now set to enter the federal banking system, marking one of the most significant regulatory endorsements of the digital asset sector to date.
